Fisher's exact test showed marginal statistical significance (<i>p</i> = 0.059).<h4>Conclusion</h4>The findings underscore the relevance of TP53 screening in populations at risk of cervical cancer, while BRCA2 screening may be less applicable in this cohort. Here, BRCA2 is linked to cervical carcinoma.